Oakwood Labs, headquartered in Cleveland, OH, is an emerging, technology-based specialty pharmaceutical company focused on hard-to-develop generic and quasi-generic, sustained-release and small molecule injectables, as well as contract manufacturing.
Oakwood partners with pharmaceutical companies on the following types of projects:
Since 1997, Oakwood has been committed to developing pharmaceutical products that provide enhanced therapeutic effects for patients. Oakwood is an industry leader in sustained-release injectable pharmaceutical development, developing and owning a patented microsphere-based drug delivery platform – called Chroniject™.
Oakwood’s vast expertise and capabilities in pharmaceuticals have led us to work on development of small molecule injectables. Oakwood can provide full formulation development and manufacturing of these products, while partners bring regulatory and sales and marketing capabilities.
To complement our formulation expertise and enhance partnering and development activities, Oakwood built and operates a sterile injectable cGMP manufacturing facility, FDA approved for commercial product manufacturing. Oakwood currently has capacity to manufacture sterile injectable products for partners.
Oakwood Labs has not received any reviews.
Oakwood Labs has not received any endorsements.